EndTB and new TB drugs: Dr. Michael Rich, Partners in Health

Dr. Michael Rich discuss endTB, the UNITAID-funded grant to Partners in Health, Medicins Sans Frontieres, and Interactive Research and Development to conduct new drug clinical trials targeting multi-drug resistant tuberculosis.  The trials will be conducted in five countries over four years.

Document Date: 12 November, 2014
Author: CAP-TB